Skip to content
value.today

Biogenic Reagents, LLC

Total raised
$28 M
5 rounds on record
Latest round
$4 M
Dec 2014
First round on record
Feb 2011
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Biogenic Reagents, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2014$4 MNo. 5$2 to $10 million

Biogenic Reagents, LLC: Raise no. 5, Dec 2014

Investors in this round

14 investors had bought by the notice of Jan 23, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Daniel A Despen · Executive Officer, Director
  • Douglas A Rohall · Executive Officer, Director
  • James A Mennell · Executive Officer, Director, Promoter
  • Enrico A Biasetti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James A. Mennell, Ceo. Source: SEC Form D, newest notice filed Jan 23, 2015. Read the notice at the SEC.

equity, optionsSEC
Jul 2013$10 MNo. 4$2 to $10 million

Biogenic Reagents, LLC: Raise no. 4, Jul 2013

Investors in this round

1 investor had bought by the notice of Jul 25, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Daniel A Despen · Executive Officer, Director
  • David A Reamer · Executive Officer
  • Douglas A Rohall · Executive Officer, Director
  • James A Mennell · Executive Officer, Director, Promoter
  • Enrico A Biasetti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James A. Mennell, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 25, 2013. Read the notice at the SEC.

equity, debtSEC
Mar 2013$2 MNo. 3$2 to $10 million

Biogenic Reagents, LLC: Raise no. 3, Mar 2013

Investors in this round

18 investors had bought by the notice of Apr 5, 2013: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Daniel Despen · Executive Officer, Director
  • David Reamer · Executive Officer
  • Douglas Rohall · Executive Officer, Director
  • James Mennell · Executive Officer, Director, Promoter
  • Enrico Biasetti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James A. Mennell, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 5, 2013. Read the notice at the SEC.

equitySEC
Dec 2011$7 MNo. 2$2 to $10 million

Biogenic Reagents, LLC: Raise no. 2, Dec 2011

Investors in this round

33 investors had bought by the notice of Nov 20, 2012: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$800,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Daniel A Despen · Executive Officer, Director
  • David A Reamer · Executive Officer
  • Douglas A Rohall · Executive Officer, Director
  • James A Mennell · Executive Officer, Director, Promoter
  • Enrico A Biasetti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James A. Mennell, Ceo. Source: SEC Form D and 2 amendments, newest notice filed Nov 20, 2012. Read the notice at the SEC.

equitySEC
Feb 2011$6 MNo. 1$2 to $10 million

Biogenic Reagents, LLC: Raise no. 1, Feb 2011

Investors in this round

16 investors had bought by the notice of Mar 8, 2011: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Daniel A Despen · Executive Officer, Director
  • David A Reamer · Executive Officer, Director
  • James A Mennell · Executive Officer, Director, Promoter
  • John S Watson · Executive Officer
  • Enrico A Biasetti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James A Mennell, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 8, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Biogenic Reagents, LLC chose not to state its revenue in its newest notice of a funding round (Jan 2015).

    SEC Form D · Jan 2015

  • The industry group it chose in its notices: Other.

    SEC Form D · Jan 2015

That is all the official record says: Biogenic Reagents, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Biogenic Reagents, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 33 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biogenic Reagents, LLC
NameRoleNamed in
Daniel A DespenExecutive officerJan 2015
Douglas A RohallExecutive officerJan 2015
James A MennellExecutive officerJan 2015
David A ReamerExecutive officerJul 2013
Daniel DespenExecutive officerApr 2013
David ReamerExecutive officerApr 2013
Douglas RohallExecutive officerApr 2013
James MennellExecutive officerApr 2013
John S WatsonExecutive officerMar 2011
Daniel A DespenDirectorJan 2015
Douglas A RohallDirectorJan 2015
Enrico A BiasettiDirectorJan 2015
James A MennellDirectorJan 2015
Daniel DespenDirectorApr 2013
Douglas RohallDirectorApr 2013
Enrico BiasettiDirectorApr 2013
James MennellDirectorApr 2013
David A ReamerDirectorMar 2011
James A MennellPromoterJan 2015
James MennellPromoterApr 2013